An ongoing clinical trial has shown that the use of a recently approved hepatitis C virus (HCV) medication could make it possible to transplant HCV-infected kidneys into non-infected patients.
Christina Mattina
Advertisement
Christina is the associate editorial director of The American Journal of Managed Care® (AJMC®) and Population Health, Equity & Outcomes, and joined AJMC in 2016. She oversees the publication of the print journals, from manuscript submission to publication, and works with the editors in chief and editorial boards to promote the journals.
She has a BS in public health from Rutgers University. You can connect with Christina on LinkedIn.
Articles by Christina Mattina
Readmission rates for both safety net hospitals and other hospitals have decreased since Medicare’s Hospital Readmissions Reduction Program went into effect in 2013. However, disparate rates of improvement could show that these hospitals in low-income areas are still at a disadvantage.
The FDA has announced a public competition to develop a mobile application that allows users to find the nearest location of the overdose-reversing drug naloxone. Here are 5 things to know about the 2016 Naloxone App Competition.
In a series of interviews with MD Magazine, Yoav Golan, MD, MS, FIDSA, discussed some health risks for patients with acute myeloid leukemia who are experiencing neutropenia.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Medicare State Rankings Reveal Stark Differences in Access, Quality, and Affordability
2
In Its 50th Year, ESMO Comes to Berlin, a City Transformed
3
Physical Activity, Vaccination May Protect Against Long COVID
4
mRNA COVID-19 Vaccines Not Associated With Major Congenital Malformations During Pregnancy
5
